Integrin-linked kinase: Not so ‘pseudo’ after all
Authors:
- P C McDonaldPMP C McDonald
- M P WalshMWM P Walsh
- S DedharSDS Dedhar
- 23 May 2011
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 30 (43) , 4375-4385
Abstract
Integrin-linked kinase (ILK) is a highly evolutionarily conserved intracellular protein that was originally identified as an integrin-interacting protein, and extensive genetic and biochemical studies have shown that ILK expression is vital during both embryonic development and tissue homeostasis. At the cellular and tissue levels, ILK regulates signaling pathways for cell adhesion-mediated cell survival (anoikis), apoptosis, proliferation and mitosis, migration, invasion, and vascularization and tumor angiogenesis. ILK also has central roles in cardiac and smooth-muscle contractility, and ILK dysregulation causes cardiomyopathies in humans. ILK protein levels are increased in several human cancers and often the expression level predicts poor patient outcome. Abundant evidence has accumulated suggesting that, of the diverse functions of ILK, some may require kinase activity whereas others depend on protein-protein interactions and are, therefore, independent of kinase activity. However, the past several years have seen an ongoing debate about whether ILK indeed functions as a protein serine/threonine kinase. This debate centers on the atypical protein kinase domain of ILK, which lacks some amino-acid residues thought to be essential for phosphotransferase activity. However, similar deficiencies are present in the catalytic domains of other kinases now known to possess protein kinase activity. Numerous studies have shown that ILK phosphorylates peptide substrates in vitro, corresponding to ILK-mediated phosphorylations in intact cells, and a recent report characterizing in vitro phosphotransferase activity of highly purified, full-length ILK, accompanied by detailed enzyme kinetic analyses, shows that, at least in vitro, ILK is a bona fide protein kinase. However, several genetic studies suggest that, not all biological functions of ILK require kinase activity, and that it can function as an adaptor/scaffold protein. Here, we review evidence for and against ILK being an active kinase, and provide a framework for strategies to further analyze the kinase and adaptor functions of ILK in different cellular contexts.Keywords
This publication has 83 references indexed in Scilit:
- Activation of AKT signaling promotes cell growth and survival in α7β1 integrin-mediated alleviation of muscular dystrophyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Integrin-Linked Kinase Controls Microtubule Dynamics Required for Plasma Membrane Targeting of CaveolaeDevelopmental Cell, 2010
- The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase!The EMBO Journal, 2009
- Structure and functional characterization of the atypical human kinase haspinProceedings of the National Academy of Sciences, 2009
- The Pseudoactive Site of ILK Is Essential for Its Binding to α-Parvin and Localization to Focal AdhesionsMolecular Cell, 2009
- α‐parvin controls vascular mural cell recruitment to vessel wall by regulating RhoA/ROCK signallingThe EMBO Journal, 2009
- The structural basis of integrin-linked kinase–PINCH interactionsProceedings of the National Academy of Sciences, 2008
- CASK Functions as a Mg2+-Independent Neurexin KinaseCell, 2008
- Phosphorylation-dependent regulation of nuclear localization and functions of integrin-linked kinaseProceedings of the National Academy of Sciences, 2007
- Integrin-linked kinase: a cancer therapeutic target unique among its ILKNature Reviews Cancer, 2005